Anyone who spends time reading research-peptide product pages quickly discovers that the field has a vocabulary of its own. A single listing might mention lyophilisation, HPLC purity, mass spectrometry, endotoxin units, trifluoroacetate salts and net peptide content, all in the space of a paragraph. To an experienced laboratory buyer these terms are second nature. To everyone else they are a wall of jargon that makes it hard to tell a well-documented product from a confidently worded one.
That gap matters. The research-peptide market is largely unregulated, and the quality of what arrives in a vial varies enormously between suppliers. The vocabulary is the only tool a buyer has to interrogate a product before purchasing it. Understanding What are peptides in the first place, and then what each analytical term on a certificate of analysis actually measures, turns a product page from a sales pitch into a data sheet you can evaluate.
The fourteen terms below are arranged roughly in the order a buyer encounters them: first the chemistry of the compound itself, then the way it is manufactured and packaged, then the analytical documentation that supports its quality, and finally the regulatory language that governs how it may be sold. Retatrutide is used as a running example throughout, since it is the compound most Canadian researchers are currently asking about and a supplier such as NOX Peptides Canada stocks it in a 30 mg research vial with full batch documentation. Nothing in this glossary is medical advice; every compound discussed is sold for laboratory research only and is not approved by Health Canada or the FDA for human use.
1. Peptide
A peptide is a chain of amino acids joined by peptide bonds, the covalent link formed between the carboxyl group of one amino acid and the amino group of the next. Chains of roughly two to fifty amino acids are usually called peptides; longer chains that fold into complex three-dimensional structures are called proteins. The boundary is conventional rather than strict, but it is a useful one, because peptides are small enough to be synthesised chemically in a laboratory rather than produced by living cells.
The research peptides that circulate today span a wide range of sizes. GHK-Cu is a tripeptide, just three residues plus a copper ion. BPC-157 has fifteen residues. Retatrutide is a considerably larger engineered molecule, built on a modified peptide backbone with a fatty-acid side chain that extends its circulating half-life. Size affects everything from synthesis cost to stability in solution, which is why the same term covers products with very different handling requirements.
2. Sequence
The sequence is the ordered list of amino acids that defines a peptide, written from the N-terminus (the end with a free amino group) to the C-terminus (the end with a free carboxyl group). Sequence is identity: two peptides with the same sequence are the same compound, and a single substituted residue makes a different molecule with potentially different activity.
Many research peptides carry modifications beyond the plain sequence. Amidation of the C-terminus, acetylation of the N-terminus, the substitution of non-natural amino acids such as aminoisobutyric acid, and the attachment of lipid chains are all common. Retatrutide, like Semaglutide and Tirzepatide, includes a fatty diacid moiety that binds serum albumin and slows clearance. A supplier’s product page should state the full sequence including modifications, and the certificate of analysis should confirm that the measured molecular weight matches it.
3. Agonist
An agonist is a molecule that binds to a receptor and activates it, producing a biological response. The word appears constantly in incretin research. Semaglutide is a GLP-1 receptor agonist. Tirzepatide is a dual agonist of the GLP-1 and GIP receptors. Retatrutide is a triple agonist that additionally activates the glucagon receptor. Its developer, Eli Lilly, has reported phase 2 data showing substantial mean weight reduction in adults with obesity, and the phase 3 TRIUMPH programme is ongoing.
Related terms include antagonist (a molecule that blocks a receptor without activating it) and partial agonist (one that activates it less than fully). A secretagogue, the term used for growth-hormone-releasing peptides such as Ipamorelin, is a compound that stimulates the release of another hormone rather than acting on the final target directly. Knowing which of these categories a compound belongs to tells you a great deal about how its research literature should be read.
4. Lyophilised
Lyophilisation, or freeze-drying, is the process of freezing a peptide solution and then removing the ice by sublimation under vacuum. What remains is a dry, porous cake or powder that can be stored far longer than any solution. Nearly every research peptide ships in this form, sealed under an inert atmosphere or vacuum in a glass vial with a rubber stopper.
A lyophilised cake should look uniform and intact. A collapsed, shrunken or discoloured cake can indicate that the vial was exposed to heat or moisture in transit, which is one of the practical arguments for buying from a domestic supplier: a vial shipped within Canada by NOX Peptides Canada spends days, not weeks, between the cold-storage shelf and the recipient’s freezer. Lyophilised peptides are typically stored at minus 20 degrees Celsius for long-term stability, though short periods at refrigerator temperature are generally tolerated.
5. Reconstitution
Reconstitution is the addition of a liquid diluent to a lyophilised peptide to produce a solution of known concentration. In research settings the diluent is usually bacteriostatic water, which contains 0.9 percent benzyl alcohol to inhibit microbial growth in a multi-use vial, or sterile water for single-use preparations. Some peptides with poor water solubility require dilute acetic acid or another specialised solvent, and the supplier’s data sheet should say so.
The arithmetic is simple but must be recorded. Adding 3 mL of diluent to a 30 mg vial yields 10 mg per mL. Adding 2 mL yields 15 mg per mL. Because a standard insulin-type syringe is graduated in units where 100 units equal 1 mL, each unit of a 10 mg per mL solution contains 100 micrograms. This is laboratory bookkeeping, not administration guidance; its purpose is to ensure that any experimental measurement is made against a known concentration. Once reconstituted, most peptides should be refrigerated and used within a limited window, since aqueous solutions degrade far faster than the dry powder.
6. Purity
Purity, in the context of a research peptide, is the percentage of the peptide-containing material that consists of the intact target sequence, as opposed to truncated sequences, deletion products, oxidised residues or other synthesis by-products. It is almost always measured by HPLC (see below) and expressed as a percentage of the peak area. A figure of 98 percent or higher is a common benchmark for research-grade material; a figure of 99 percent or higher is better.
Purity is frequently misread. It does not tell you how much peptide is in the vial, only what fraction of the peptide material is the correct molecule. A vial can be 99 percent pure and still contain far less than its labelled mass if the manufacturer did not account for water and salt content (see net peptide content). Purity also says nothing about microbial or endotoxin contamination. It is one line on a certificate of analysis, not the whole document.
7. HPLC
High-performance liquid chromatography is the standard technique for measuring peptide purity. A small sample of the reconstituted peptide is pumped through a column packed with fine particles; different molecules travel through the column at different speeds depending on their chemical properties, and a detector records when each one emerges. The result is a chromatogram: a trace with one large peak for the target peptide and smaller peaks for impurities. Purity is calculated from the relative area of the main peak.
A trustworthy COA shows the chromatogram itself, not just the number derived from it. The shape of the trace tells an experienced reader a great deal. A single sharp peak with a flat baseline suggests a clean synthesis; a cluster of shoulders and satellite peaks near the main peak suggests deletion sequences that the purification step failed to remove. When a supplier reports “99.2 percent by HPLC” without showing the trace, the buyer has no way to check the claim.
8. Mass Spectrometry
Where HPLC measures how pure a sample is, mass spectrometry confirms what it is. The instrument ionises the peptide and measures its mass-to-charge ratio, producing a value that can be compared with the theoretical molecular weight calculated from the sequence. If the measured mass matches within the instrument’s tolerance, the identity of the compound is confirmed. If it does not, the vial contains something other than what the label says, however pure that something may be.
The two techniques are complementary and a complete COA reports both. Some laboratories combine them into a single LC-MS run, in which the eluent from the chromatography column feeds directly into the mass spectrometer. For an engineered molecule such as Retatrutide, with its lipid side chain and non-standard residues, mass confirmation is particularly important, because a synthesis error in the modification step produces a molecule that may look similar on HPLC but has the wrong mass and potentially different receptor activity.
9. Certificate of Analysis (COA)
A certificate of analysis is the document that records the analytical testing performed on a specific batch of product. At minimum it should carry the product name and sequence, a batch or lot number, the date of testing, the name of the laboratory that performed the tests, the methods used, and the results. A good COA includes the HPLC chromatogram and mass spectrum rather than just the summary values.
Two qualifiers make a COA worth trusting. The first is that it is batch-specific: a document dated two years ago for a different lot tells you nothing about the vial you are buying. The second is that it is third-party: testing performed by an independent laboratory rather than the seller’s own bench removes the most obvious conflict of interest. Suppliers that publish batch-specific, third-party COAs on the product page itself, as NOX Peptides Canada does for its Retatrutide 30 mg listing, are setting the standard that every other listing should be judged against.
10. Net Peptide Content
Net peptide content is the percentage of the total powder mass that is actually peptide, as opposed to bound water, counter-ions and residual salts. Lyophilised peptides are hygroscopic, and the synthesis process leaves them as salts, so a vial of nominally 30 mg material may contain anywhere from around 70 to 90 percent peptide by weight, with the remainder being water and counter-ions.
This is one of the least understood figures in the field, and one of the most consequential for any quantitative experiment. A vial labelled by gross weight with 80 percent net peptide content contains 24 mg of peptide, not 30. A vial labelled by net peptide content contains the full 30 mg of peptide and correspondingly more total powder. Suppliers are not consistent about which convention they use, and a buyer who needs an exact concentration should ask. Net peptide content is measured by amino acid analysis or by elemental nitrogen determination, and it is a separate test from HPLC purity.
11. Trifluoroacetate (TFA) Salt
Trifluoroacetic acid is used during solid-phase peptide synthesis to cleave the finished peptide from its resin support and during HPLC purification as a mobile-phase modifier. Because it is a strong acid, it pairs with the basic residues of the peptide to form a trifluoroacetate salt, and residual TFA is present in nearly every synthetic peptide unless it is deliberately exchanged for another counter-ion such as acetate or hydrochloride.
Residual TFA matters for two reasons. It contributes to the non-peptide mass discussed under net peptide content, and it can affect cell-based assays, since trifluoroacetate is biologically active at surprisingly low concentrations. Some suppliers offer acetate salt forms for this reason. A COA that reports TFA content, or that specifies the counter-ion, is more complete than one that ignores the question.
12. Endotoxin
Endotoxins are lipopolysaccharide fragments from the outer membrane of Gram-negative bacteria. They are heat-stable, survive filtration, and provoke strong inflammatory responses in mammalian tissue at very low concentrations. Their presence in a peptide preparation indicates bacterial contamination at some stage of manufacture or handling, and they are measured with the Limulus amoebocyte lysate (LAL) assay or a recombinant equivalent, with results reported in endotoxin units per milligram or per vial.
Endotoxin testing is not universal in the research-peptide market, which is itself informative. A supplier that includes an endotoxin result on the COA has gone beyond the minimum, and a low or non-detectable result is a meaningful quality signal. Note that endotoxin testing is distinct from sterility testing, which checks for viable microorganisms rather than their residues; the two tests answer different questions and a thorough COA may include both.
13. Research Use Only
“Research use only” or “for laboratory research purposes only” is the regulatory classification under which research peptides are sold. It means the product has not been manufactured under the pharmaceutical Good Manufacturing Practice standards required for medicines, has not been evaluated by Health Canada or the FDA for safety or efficacy in humans, and is not intended for human or veterinary use. The phrase is not a disclaimer to be skimmed past; it is an accurate description of the product’s status.
For Retatrutide the classification is especially clear. The compound has completed phase 2 trials and is in the phase 3 TRIUMPH programme, but it has no regulatory approval anywhere in the world. The only version that exists as an approved medicine is the one that does not yet exist. A supplier that markets Retatrutide with implied human benefits, dosing schedules or before-and-after imagery is misrepresenting a research reagent. A supplier that labels it plainly, documents it thoroughly and declines to offer usage guidance is behaving correctly.
14. Cold Chain
The cold chain is the sequence of temperature-controlled storage and transport steps between the manufacturer and the end user. For lyophilised peptides it is less demanding than for vaccines or reconstituted biologics, since the dry powder tolerates brief excursions to room temperature, but prolonged heat during shipping degrades the product, and repeated freeze-thaw cycles after reconstitution degrade it faster still.
The length and unpredictability of the shipping route is the main cold-chain risk for Canadian buyers. An overseas parcel may sit in a customs facility or a summer delivery van for days at a time; a domestic shipment moves through a shorter, more predictable chain. This is one of the practical reasons researchers in Canada favour a domestic supplier: NOX Peptides Canada stores its inventory cold and ships within the country, which keeps transit time short and temperature exposure limited. On arrival, the vial should go into the freezer promptly and the arrival date noted on the label.
Frequently Asked Questions
Is a 99 percent purity figure enough on its own to trust a product?
No. Purity tells you what fraction of the peptide material is the correct sequence, but it says nothing about whether the vial contains the labelled mass, whether the identity has been confirmed by mass spectrometry, or whether endotoxin or residual solvents are present. A single purity number without a batch-specific, third-party COA behind it should be treated as a claim rather than a measurement.
Why do different suppliers quote different masses for what seems to be the same product?
Usually because they use different conventions for net peptide content. One supplier may label the gross weight of the lyophilised powder including water and salts; another may label the net weight of the peptide itself. The second convention gives the buyer more peptide for the same nominal figure. Ask which convention applies before comparing prices.
What does “triple agonist” mean in Retatrutide’s description?
It means the molecule activates three distinct receptors: GLP-1, GIP and glucagon. Semaglutide acts on one of these, Tirzepatide on two. Retatrutide is an investigational compound from Eli Lilly; its phase 2 trial reported substantial mean weight reduction and phase 3 trials are ongoing. It is not approved for human use and is available only as a research reagent.
How long does a reconstituted peptide remain usable?
It depends on the peptide, the diluent and the storage temperature, and the supplier’s data sheet is the best source. As a general rule, aqueous solutions stored at refrigerator temperature degrade over a period of weeks, while lyophilised powder stored frozen remains stable for months to years. Bacteriostatic water slows microbial growth but does not stop chemical degradation of the peptide itself.
Final Thoughts
Vocabulary is leverage. A buyer who knows the difference between purity and net peptide content, between HPLC and mass spectrometry, and between a supplier’s own assay and an independent one can read a product page the way a laboratory manager would and spot the gaps immediately. A buyer who does not is left comparing adjectives.
The good news is that reputable suppliers make this easy by publishing the information up front. The Retatrutide 30 mg research vial at NOX Peptides Canada is listed with its batch-specific, third-party COA, stored cold and shipped domestically, which covers most of the terms in this glossary in a single product page. Whatever the supplier, the principle is the same: every term above corresponds to a question, and a product that cannot answer the question has not earned the purchase. None of this is medical advice, and every compound discussed remains an investigational research reagent, not an approved medicine.
